Pyrrolidine-2-carboxamide derivatives as prostaglandin e2 receptor 4 (EP4) agonists for the treatment of gastrointestinal and pulmonary diseases
HRP20260825T1Active Publication Date: 2026-08-28NXERA PHARMA UK LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- HRP20260825T
- Authority / Receiving Office
- HR · HR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2023-08-02
- Filing Date
- 2023-08-02
- Publication Date
- 2026-08-28
- Estimated Expiration
- 2043-08-02
Need to check novelty before this filing date? Find Prior Art
No text content released.